Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Prevalence of Osteoporosis/Osteopenia in Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis Publisher Pubmed



Azadvari M1 ; Mirmosayyeb O2, 3 ; Hosseini M4 ; Vaheb S5 ; Razavi SZE4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Physical Medicine and Rehabilitation, Sina & Imam Khomeini Hospital, Tehran Medical University, Tehran, Iran
  2. 2. Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Universal Council of Epidemiology (UCE), Universal Scientific Education and Research Network (USERN), Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Physical Medicine and Rehabilitation, Imam Khomeini Hospital, Tehran Medical University, Tehran, Iran
  5. 5. Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Neurological Sciences Published:2022


Abstract

Background: The prevalence of osteoporosis is reported differently. We designed this systematic review and meta-analysis to estimate pooled prevalence of osteoporosis and osteopenia in patients with MS. Methods: Independently, two researchers searched PubMed, Scopus, EMBASE, Web of Science, and google scholar along with gray literature (conference abstracts and references of the references) up to March 2021. We collected data regarding first author, country of origin, number of enrolled patients, number cases with osteoporosis/ osteopenia, mean age, F/M ratio, mean EDSS, and mean duration of the disease. Results: Literature search revealed 847 articles and 658 remained after deleting duplicates. Finally, 29 original articles and 6 conference papers remained for meta-analysis. A total of 13,906 patients were evaluated. The pooled prevalence of osteoporosis was 17% (95% CI: 14–20%) (I2 = 90.4%, p < 0.001). The pooled prevalence of osteopenia was 43% (95% CI: 35–51%) (I2 = 97.9%, p < 0.001). Conclusion: Osteoporosis/osteopenia should be considered in patients with MS. © 2022, Fondazione Societa Italiana di Neurologia.
Experts (# of related papers)
Other Related Docs
13. Effect of Fatty Acids on Bone Health and Osteoporosis, Journal of Babol University of Medical Sciences (2013)
16. Osteoporosis Screening Tools in Iranian Postmenopausal Women, Iranian Red Crescent Medical Journal (2010)
30. Antioxidant and Bone; Protect Your Future: A Brief Review, Iranian Journal of Public Health (2021)
39. Normative Bone Mineral Density Values in Isfahani Women, Journal of Research in Medical Sciences (2005)
46. Evaluation of Bone Loss in Diabetic Postmenopausal Women, Journal of Research in Medical Sciences (2012)
49. Intravenous Bisphosphonates for Postmenopausal Osteoporosis, Journal of Research in Medical Sciences (2010)